Form 4: RB Global CLO Acquires Dividend Rights
Insider Transaction Report
RB Global's Chief Legal Officer, Darren Jeffrey Watt, acquired dividend equivalent rights tied to restricted share units, increasing his beneficial ownership.
Summary
- Darren Jeffrey Watt, Chief Legal Officer of RB Global Inc. (RBA), acquired Dividend Equivalent Rights (DERs) on September 18, 2025.
- The acquisition included 2 DERs related to 2023 Restricted Share Units (RSUs), 4 DERs related to 2024 RSUs, and 5 DERs related to 2025 RSUs.
- Each DER represents a contingent right to receive the economic equivalent of one RBA common share, vesting proportionately with the underlying RSUs.
- The acquisition price for these derivative securities was $0, indicating they were granted as part of compensation.
- Following these transactions, Watt's beneficial ownership of DERs stands at 28 for 2023 RSUs, 26 for 2024 RSUs, and 10 for 2025 RSUs.
Sentiment
Score: 6
Explanation: Slightly positive, as it indicates an increase in an executive's beneficial ownership, aligning interests with shareholders, though it is a routine compensation grant rather than a direct purchase.
Positives
- The acquisition of Dividend Equivalent Rights by a key executive, Darren Jeffrey Watt, aligns his interests with those of shareholders by increasing his beneficial ownership in the company's equity-linked compensation.
Negatives
- The transaction represents a grant of derivative securities as compensation rather than an open market purchase, which typically signals stronger insider confidence.
Future Outlook
The Dividend Equivalent Rights become exercisable proportionately with the underlying Restricted Share Units (RSUs) to which they relate, indicating future vesting events for these equity-linked compensation awards.
Industry Context
The grant of Dividend Equivalent Rights in conjunction with Restricted Share Units is a common practice in executive compensation across various industries, designed to provide executives with the economic benefits of share ownership, including dividends, before the full vesting of their equity awards.
Comparison to Industry Standards
- The structure of granting Dividend Equivalent Rights alongside Restricted Share Units is a standard component of long-term incentive plans for executives in publicly traded companies, comparable to practices seen in many S&P 500 firms.
- The 'price $0' for these derivative securities is typical for compensation grants, reflecting their nature as part of an executive's total remuneration package rather than a direct investment.
Stakeholder Impact
- Shareholders: The increase in beneficial ownership by a key executive may be viewed positively as it enhances alignment between management and shareholder interests.
Next Steps
- The Dividend Equivalent Rights will become exercisable proportionately with the vesting of the associated 2023, 2024, and 2025 Restricted Share Units.
Key Dates
| Date | Description |
|---|---|
| 09/18/2025 | Date of transaction for the acquisition of Dividend Equivalent Rights. |
| 09/22/2025 | Date the Form 4 was signed by Maria Teresa Punsalan, attorney-in-fact for Darren Jeffrey Watt. |
Recommendation
holdThis Form 4 filing details a routine grant of equity-linked compensation to a Chief Legal Officer. While it increases the executive's beneficial ownership, it does not represent a significant market signal for the company's fundamental performance or future prospects that would warrant a change in investment recommendation. It is a standard compensation event.
Keywords
RB Global, RBA, insider transaction, Form 4, dividend equivalent rights, restricted share units, executive compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.